相关实验视频
Updated: Aug 17, 2025

07:20
Author Spotlight: Imaging ATG9A, a Multi-Spanning Membrane Protein
Published on: June 16, 2023
2.2K
通过非传统的溶酶体向途径,ATG9A可以防止TNF细胞毒性
Jon Huyghe1,2, Dario Priem1,2, Lisette Van Hove1,2
1VIB Center for Inflammation Research, 9052 Ghent, Belgium.
概括
瘤死亡因子 (TNF) 可以导致细胞死亡,但涉及ATG9A和FIP200的新检查点通过降解细胞毒性复合物来防止这种情况. 这种机制可以防止TNF受体1 (TNFR1) 介导的胚胎死亡和皮肤炎症.
科学领域:
- 免疫学
- 细胞生物学
- 分子生物学
背景情况:
- 瘤死因 (TNF) 在免疫系统中起着双重作用,帮助感染反应,同时也导致炎症性疾病.
- 细胞死亡检查点通常抑制TNF诱导的细胞毒性,以防止有害影响.
- 这些检查点的失活使得TNF能够诱导细胞死亡.
研究的目的:
- 识别和描述一种新型的细胞死亡检查点,该检查点调节TNF诱导的细胞灭绝.
- 阐明这个检查点防止细胞毒性的分子机制.
- 在体内调查这个检查点的生理相关性.
主要方法:
- 研究了TNF诱导的细胞死亡途径和复杂的形成.
- 在细胞和小鼠模型中利用与自相关的9A (ATG9A) 和FIP200.
- 检查了溶酶体向和降解途径,包括LC3独立的机制.
- 评估确定检查点在TNFR1介导的胚胎死亡率和皮肤炎症中的作用.
主要成果:
- 描述了一个检查点,通过在TNF感知时形成的细胞毒性复合体IIa进行解毒来防止细胞灭绝.
- 证明ATG9A和FIP200通过LC3独立的溶酶体途径促进复合IIa的降解.
- 表明这种解毒机制可以抵消TNFR1介导的小鼠胚胎死亡.
- 在小鼠模型中证实了对炎症性皮肤疾病的保护作用.
结论:
- 一个涉及ATG9A和FIP200的新型细胞死亡检查点通过溶解体降解复合IIa来调节TNF诱导的细胞亡.
- 这种机制对于预防TNF介导的有害炎症反应和胚胎致死性至关重要.
- 了解这种途径可以了解控制TNF驱动的病理.
相关概念视频
Cytotoxic T Cells-mediated Immune Response
1.1K
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
1.1K
TGF - β Signaling Pathway
7.6K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.6K
Receptor Downregulation in MVBs
2.1K
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR...
2.1K
Export of Misfolded Proteins out of the ER
3.7K
After folding, the ER assesses the quality of secretory and membrane proteins. The correctly folded proteins are cleared by the calnexin cycle for transport to their final destination, while misfolded proteins are held back in the ER lumen. The ER chaperones attempt to unfold and refold the misfolded proteins but sometimes fail to achieve the correct native conformation. Such terminally misfolded proteins are then exported to the cytosol by ER-associated degradation or ERAD pathway for...
3.7K
The Extrinsic Apoptotic Pathway
6.5K
The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
6.5K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
210
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
210

